Cita APA

Scalvenzi, M., Cappello, M., Costa, C., Fabbrocini, G., Luciano, M., & Villani, A. (2020). Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity. Dermatol Ther (Heidelb).

Citación estilo Chicago

Scalvenzi, Massimiliano, Milena Cappello, Claudia Costa, Gabriella Fabbrocini, Mariaantonietta Luciano, y Alessia Villani. "Low-Dose Vismodegib As Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy With Minimal Toxicity." Dermatol Ther (Heidelb) 2020.

Cita MLA

Scalvenzi, Massimiliano, et al. "Low-Dose Vismodegib As Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy With Minimal Toxicity." Dermatol Ther (Heidelb) 2020.